Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

Hey iluvcrap: it was 500 million SHARES traded...not

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
I_luv_cydy Member Profile
 
Followed By 5
Posts 441
Boards Moderated 0
Alias Born 06/24/16
160x600 placeholder
Sorrento: The Monoclonal Antibody Portfolio Charges Ahead TipRanks - 4/30/2021 7:46:13 AM
Sorrento rises 6% as FDA OKs phase 2 study of monoclonal antibody for carcinoma Seeking Alpha - 4/27/2021 12:25:02 PM
Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 Antibody, for Advanced Urothelial C... GlobeNewswire Inc. - 4/27/2021 11:39:47 AM
Sorrento achieves 100% discharge rate in COVI-MSC study in COVID-19 Seeking Alpha - 4/20/2021 9:20:02 AM
Sorrento Announces Positive Results of Phase 1b Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 o... GlobeNewswire Inc. - 4/20/2021 9:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/20/2021 6:04:06 AM
Sorrento’s Subsidiary Scilex Gets FDA Nod For ZTlido Label Expansion TipRanks - 4/12/2021 5:43:31 AM
Sorrento Therapeutics files to sell ~851K shares from shareholder Seeking Alpha - 4/9/2021 6:01:29 PM
Scilex Holding gets FDA sNDA approval for Ztlido label expansion Seeking Alpha - 4/9/2021 3:16:16 PM
Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion GlobeNewswire Inc. - 4/9/2021 3:00:47 PM
Is Sorrento Stock a Buy Following ACEA Acquisition? Analyst Weighs In TipRanks - 4/7/2021 6:50:00 PM
Sorrento Inks Deal To Buy ACEA Therapeutics; Shares Gain 3% TipRanks - 4/6/2021 9:17:36 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/6/2021 6:05:15 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 4/6/2021 6:02:31 AM
Sorrento to acquire to acquire late-stage oncology company ACEA Therapeutics Seeking Alpha - 4/5/2021 9:29:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 9:11:48 AM
Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics GlobeNewswire Inc. - 4/5/2021 9:00:00 AM
Why Sorrento Is a $26 Stock TipRanks - 3/29/2021 1:05:12 PM
Sorrento posts updated results from early-stage COVID-19 trial Seeking Alpha - 3/25/2021 4:07:42 PM
Sorrento posts updated results from early-stage COVID-19 trial Seeking Alpha - 3/25/2021 4:07:02 PM
Sorrento posts updated results from early-stage COVID-19 trial Seeking Alpha - 3/25/2021 4:06:14 PM
Sorrento Announces Updated Positive Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients GlobeNewswire Inc. - 3/25/2021 3:58:45 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 3/19/2021 4:32:09 PM
Sorrento says first patient treated in early-stage Amyloidosis study Seeking Alpha - 3/18/2021 9:41:18 AM
Sorrento Announces First Patient Treated in Phase IB AL Amyloidosis Trial with STI-6129, an Anti-CD38 Antibody-Drug Conjugate... GlobeNewswire Inc. - 3/18/2021 9:00:00 AM
I_luv_cydy   Friday, 05/15/20 11:14:16 PM
Re: iluvcrap2000 post# 2284
Post # of 10021 
Hey iluvcrap: it was 500 million SHARES traded...not 500 million TRADES. Unreal volume. Never saw anything close to that.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences